{"id":399,"date":"2016-01-21T08:19:52","date_gmt":"2016-01-21T14:19:52","guid":{"rendered":"http:\/\/www.illinoisinjurylawyerblog.net\/?p=399"},"modified":"2018-04-23T11:44:26","modified_gmt":"2018-04-23T16:44:26","slug":"supreme-court-allows-124-million-judgment-drug-company-stand","status":"publish","type":"post","link":"https:\/\/www.molllawgroup.com\/blog\/supreme-court-allows-124-million-judgment-drug-company-stand\/","title":{"rendered":"Supreme Court Allows $124 Million Judgment Against Drug Company to Stand"},"content":{"rendered":"

According to a news article<\/a>, the U.S. Supreme Court recently refused to hear a drug-maker\u2019s appeal in a case that cost the drug company $124 million for falsely marketing a prescription medication. By declining the appeal, the court affirmed a South Carolina Supreme Court ruling that reduced the company\u2019s damages from $327 million to $124 million, but it did not overturn a jury\u2019s verdict that the drug company had improperly marketed the medication.<\/p>\n

How Cases Get to the Supreme Court<\/strong><\/p>\n

Cases come to the supreme court in one of two ways. First, a case can be appealed to the court from a lower federal court ruling. These courts are called federal circuit courts. Second, a case can come to the supreme court from a state\u2019s highest court. In either case, if the supreme court does not accept the appeal, the lower court\u2019s decision stands.<\/p>\n

What Happened in This Case?<\/strong><\/p>\n

The drug at issue in the South Carolina case is called Risperdal. Risperdal was introduced in 1994 for the treatment of schizophrenia and bipolar disorder. It is also given to patients with autism who suffer from irritability and aggressiveness. Side effects of the medication include diabetes, stroke, and weight gain.<\/p>\n

Continue reading \u2192<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

According to a news article, the U.S. Supreme Court recently refused to hear a drug-maker\u2019s appeal in a case that cost the drug company $124 million for falsely marketing a prescription medication. By declining the appeal, the court affirmed a South Carolina Supreme Court ruling that reduced the company\u2019s damages from $327 million to $124 […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[19,34],"tags":[],"class_list":["post-399","post","type-post","status-publish","format-standard","hentry","category-dangerous-products","category-prescription-drug-injuries"],"yoast_head":"\nSupreme Court Allows $124 Million Judgment Against Drug Company to Stand — Illinois Injury and Mass Tort Lawyer Blog — January 21, 2016<\/title>\n<meta name=\"description\" content=\"According to a news article, the U.S. Supreme Court recently refused to hear a drug-maker\u2019s appeal in a case that cost the drug company $124 million for — January 21, 2016\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.molllawgroup.com\/blog\/supreme-court-allows-124-million-judgment-drug-company-stand\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Supreme Court Allows $124 Million Judgment Against Drug Company to Stand — Illinois Injury and Mass Tort Lawyer Blog — January 21, 2016\" \/>\n<meta name=\"twitter:description\" content=\"According to a news article, the U.S. Supreme Court recently refused to hear a drug-maker\u2019s appeal in a case that cost the drug company $124 million for — January 21, 2016\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Moll Law Group\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Supreme Court Allows $124 Million Judgment Against Drug Company to Stand — Illinois Injury and Mass Tort Lawyer Blog — January 21, 2016","description":"According to a news article, the U.S. Supreme Court recently refused to hear a drug-maker\u2019s appeal in a case that cost the drug company $124 million for — January 21, 2016","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.molllawgroup.com\/blog\/supreme-court-allows-124-million-judgment-drug-company-stand\/","twitter_card":"summary_large_image","twitter_title":"Supreme Court Allows $124 Million Judgment Against Drug Company to Stand — Illinois Injury and Mass Tort Lawyer Blog — January 21, 2016","twitter_description":"According to a news article, the U.S. Supreme Court recently refused to hear a drug-maker\u2019s appeal in a case that cost the drug company $124 million for — January 21, 2016","twitter_misc":{"Written by":"Moll Law Group","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.molllawgroup.com\/blog\/supreme-court-allows-124-million-judgment-drug-company-stand\/","url":"https:\/\/www.molllawgroup.com\/blog\/supreme-court-allows-124-million-judgment-drug-company-stand\/","name":"Supreme Court Allows $124 Million Judgment Against Drug Company to Stand — Illinois Injury and Mass Tort Lawyer Blog — January 21, 2016","isPartOf":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#website"},"datePublished":"2016-01-21T14:19:52+00:00","dateModified":"2018-04-23T16:44:26+00:00","author":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90"},"description":"According to a news article, the U.S. Supreme Court recently refused to hear a drug-maker\u2019s appeal in a case that cost the drug company $124 million for — January 21, 2016","breadcrumb":{"@id":"https:\/\/www.molllawgroup.com\/blog\/supreme-court-allows-124-million-judgment-drug-company-stand\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.molllawgroup.com\/blog\/supreme-court-allows-124-million-judgment-drug-company-stand\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.molllawgroup.com\/blog\/supreme-court-allows-124-million-judgment-drug-company-stand\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.molllawgroup.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Supreme Court Allows $124 Million Judgment Against Drug Company to Stand"}]},{"@type":"WebSite","@id":"https:\/\/www.molllawgroup.com\/blog\/#website","url":"https:\/\/www.molllawgroup.com\/blog\/","name":"Illinois Injury and Mass Tort Lawyer Blog","description":"Published by Illinois Injury and Mass Tort Attorney \u2014 Moll Law Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.molllawgroup.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90","name":"Moll Law Group","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","caption":"Moll Law Group"}}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/399","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/comments?post=399"}],"version-history":[{"count":2,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/399\/revisions"}],"predecessor-version":[{"id":2214,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/399\/revisions\/2214"}],"wp:attachment":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/media?parent=399"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/categories?post=399"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/tags?post=399"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}